Expedited Investigational New Drug (IND) pilot program webinar
U.S. Food and Drug Administration · August 7, 2026
FDA officials outlined Operation Trialblazer and an expedited IND pilot to speed first‑in‑human clinical trials, describing a rolling submission model using qualified research institutions, a Phase 1 IND navigator resource, proposed metrics, and a timeline for applications and selection.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.